Pharma M&A

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business 🔮 fades

AbbVie’s $10.9B bid for Apogee Therapeutics signals a high-stakes bet on next-gen autoimmune treatments—including a rival to Dupixent.

6 sources 6 articles v 4 1d ago